Correspondence between the site of SMAD4 mutation and tumor morphology was demonstrated directly in a case of mixed adenocarcinoma and neuroendocrine tumor (Case #20, S1 Table). The gene discussed is SMAD4; the disease is neuroendocrine neoplasm.